Leading Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LEADING, and what generic and branded alternatives to LEADING drugs are available?
LEADING has nineteen approved drugs.
Drugs and US Patents for Leading
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leading | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 073250-001 | Oct 8, 1991 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Leading | NYSTATIN | nystatin | SUSPENSION;ORAL | 214346-001 | Mar 10, 2022 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Leading | FUROSEMIDE | furosemide | TABLET;ORAL | 077293-003 | Nov 9, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Leading | LORAZEPAM | lorazepam | TABLET;ORAL | 078203-001 | Jul 30, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Leading | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 040903-001 | Oct 24, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.